First human test for potential breast cancer drug begins
NCT ID NCT07300202
Summary
This early-stage study tested a new drug called Orialpha (BD-C) in 15 healthy adults to check its safety. The main goal was to find the highest dose people can take without serious side effects. This is the first step in research that could one day lead to a treatment for breast cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hanoi Medical University
Hanoi, Hanoi, 100000, Vietnam
Conditions
Explore the condition pages connected to this study.